Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
STEM & Life Science Courses › MSc in Biotherapeutics
General Pharma & Life Science

MSc in Biotherapeutics

Dublin City University (DCU) Postgraduate (L9) Blended

Career prospects

Graduates will be well placed to provide practice, professional leadership, innovation and scholarship expertise to a vast array of organisations to make a difference in the development and application of biotherapeutics.

Entry requirements

To qualify for the MSc in Biotherapeutics programme students will be expected to have a Second Class Honours degree (H2.1) or equivalent in a life science, pharmaceutical or chemistry discipline. Medical graduates must have a MB, BCh, BAO or equivalent from a recognised medical school. Applicants with equivalent qualifications in related areas of science and technology, or with proven and relevant industrial experience from the Healthcare/Medical/Therapeutics industry may be considered for places following interview and assessment by the programme management team.

Where this leads
General Pharma & Life Science

Broad life-science foundations spanning several of the above areas.

Graduate entry roles: €30,000 – €38,000 across R&D, Manufacturing, Quality, Regulatory and Design Assurance tracks
Source: Life Science Recruitment 2026; CSO Earnings & Labour Costs Q1 2026
See full career intelligence for General Pharma & Life Science →

Course facts

LevelPostgraduate (L9)
Study modePart-time / Flexible
Duration1 year full-time, 2 years part-time
FeePaid
LocationGlasnevin
View DCU →